Preeclampsia (PE) and intrauterine growth restriction (IUGR) are clinical manifestations of placental insufficiency. These complications affect 5-15% of pregnancies, and are responsible for up to 20% of preterm births. Women who develop PE during pregnancy also have an increased risk for cardiovascular events, both at short and long term. This justifies the need to improve diagnostic tools to identify patients at risk for these complications. PE and IUGR are multifactorial entities. Screening algorithms should thus include several parameters to achieve high detection rates. Research has mainly focused in the analysis of biophysical and biochemical parameters, and the study of the placenta itself has not been included in current diagnostic strategies. Investigators hypothesize that detection rates of preeclampsia and intrauterine growth restriction could be improved by the study of placental characteristics in the first trimester of pregnancy.
Study Type
OBSERVATIONAL
Enrollment
1,390
The placenta will be scanned to measure the placental volume, chorionic plate, basal plate and thickness.
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Development of preeclampsia
Pre-eclampsia is diagnosed after 20 week of gestation with systolic blood pressure equal to or greater than 140 mmHg, diastolic blood pressure equal to or greater than 90 mmHg and proteinuria greater than or equal 0.3 g/d by 24 hour urine collection
Time frame: Up to birth
Development of intrauterine growth restriction
Intrauterine growth restriction is defined as birthweight below 10th centile according to local standards
Time frame: At birth
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.